Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
/j.micres.2025.128082 ). This project aims to dissect the biology of this novel group of jumbophage using a combination of genetics, molecular biology, proteomics, epifluorescence microscopy and electron
-
), Eq3 (3D liver models), and Eq4 (Germany, redox chemistry, and proteomics). The objectives are to: - Develop a plasma jet to treat pathological liver tissue in situ, and analyze the physicochemical
-
. Candidates with background knowledge and hands-on experience in mouse models, proteomics, 3Dorganoids,primary cells purification and culture skills are particularly welcome. Minimum Requirements: Ph.D
-
in vitro and in living cells The applicant will benefit from access to centralized facilities (in particular Nanobody technology, proteomics, cutting-edge microscopy and structural biology). Please
-
transcriptomics, proteomics, lipidomics, genomics, optogenetics and histology. Lab website: eleannakaralab.com Under the direction of the Principal Investigator, the incumbent will work on a project in a laboratory
-
(https://www.science.org/doi/10.1126/science.adu8000 ). We apply this technology to developing novel genetic tools to probe gut ecosystem and host-microbiome interactions, as well as engineering living
-
for scalability and resilience, as well as indexes on key fields (sample ID, gene/protein, variant, peptide) for the various possible queries. Where to apply Website https://www.unipa.it/albo.html Requirements
-
, epigenetics, metabolomics, proteomics, and/or chronobiology, as well as related intervention trials and/or observational population studies. Food and its ingredients: the ability to assess the impact of foods
-
Appointment Term: 1-2 years Appointment Start Date: January 2026 Group or Departmental Website: https://greiciuslab.stanford.edu/ (link is external) How to Submit Application Materials: Please email application
-
progression. Using murine and humanized models, human patient samples, single-cell multiomics (CITE-seq), advanced flow cytometry, proteomics, and mechanistic studies, we aim to identify therapeutic targets